Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 21 01:53PM ET
14.13
Dollar change
+1.02
Percentage change
7.78
%
Index- P/E- EPS (ttm)-0.82 Insider Own24.80% Shs Outstand8.13M Perf Week36.39%
Market Cap114.84M Forward P/E- EPS next Y- Insider Trans0.10% Shs Float5.24M Perf Month-
Income-5.10M PEG- EPS next Q- Inst Own46.90% Short Float- Perf Quarter-
Sales- P/S- EPS this Y-39.30% Inst Trans-53.94% Short Ratio- Perf Half Y-
Book/sh-0.58 P/B- EPS next Y- ROA-146.70% Short Interest- Perf Year-
Cash/sh0.02 P/C574.20 EPS next 5Y- ROE342.30% 52W Range8.50 - 14.19 Perf YTD63.35%
Dividend Est.- P/FCF- EPS past 5Y- ROI-82.50% 52W High-0.42% Beta-
Dividend TTM- Quick Ratio0.10 Sales past 5Y- Gross Margin100.00% 52W Low66.24% ATR (14)1.76
Dividend Ex-Date- Current Ratio0.20 EPS Y/Y TTM- Oper. Margin- RSI (14)- Volatility12.18% -
Employees29 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / No LT Debt/Eq- EPS Q/Q-225.30% Payout0.00% Rel Volume0.73 Prev Close13.11
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume40.79K Price14.13
SMA2021.04% SMA5021.04% SMA20021.04% Trades Volume20,464 Change7.78%
Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. Our objective with SimplePath, our biomanufacturing platform, is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. We believe that SimplePath not only can maximize the value of these resources but also will contribute to the development of novel chemical compounds that should open new markets and business opportunities.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heltzen MichaelChief Executive OfficerNov 15 '24Buy11.101,98422,0221,984Nov 19 06:45 PM